Smith, S. M., Struyk, A., Jonathan, D., Declercq, R., Marcus, J., Toolan, D., Wang, X., Schachter, J. B., Cosden, M., Pearson, M., Hess, F., Selnick, H., Salinas, C., Li, W., Duffy, J., McEachern, E., Vocadlo, D., Renger, J. J., Eric, H. D., Forman, M., & Schoepp, D. (n.d.). o2‐13‐04: Early Clinical Results and Preclinical Validation of the O‐Glcnacase (OGA) Inhibitor Mk‐8719 as a Novel Therapeutic for the Treatment of Tauopathies. Alzheimer's & dementia, 12, P261. http://access.bl.uk/ark:/81055/vdc_100102762723.0x000018